Summary

Original source:
http://www.usatoday.com/news/health/2005-01-16-cholesterol-usat_x.htm

Details

• Although a Food and Drug Administration advisory panel has recommended against selling one cholesterol-lowering statin drug over-the-counter (OTC), the maker of another is moving forward with plans to seek the agency's permission to make the switch.
• Hutchison declined to say when his company plans to submit an application to the FDA for OTC Pravachol, which would be marketed by Bayer.
• Hutchison's comments come after an FDA advisory panel voted 20-3 Friday to recommend against allowing drugmaker Merck to sell OTC Mevacor.
• Panel members said Merck's "actual use" study, which simulated pharmacies selling OTC Mevacor, failed to show that consumers could properly decide on their own whether to take the statin.
• Nearly six out of 10 study participants who used OTC Mevacor still ended up consulting a doctor.
• And even so, nine out of 10 failed to meet at least one of the criteria set forth on the drug's label, such as an LDL cholesterol level of 130 to 170 or under age 55 for women.
• Use by premenopausal women raised committee members' concerns about the possible harm of statin use early in pregnancy.
• By switching a drug to OTC status, manufacturers hope to boost sagging sales resulting from generic competition.
• Prescription Mevacor already is off patent, so it faces competition from generic lovastatin.
• OTC Mevacor would have been the first non-prescription drug to treat a symptomless chronic condition.
• Many committee members say they wished that in the USA, non-prescription Mevacor could be sold the same way that non-prescription Zocor, another Merck statin, is sold in the U.K. Before a prescription drug goes over-the-counter in the U.K., it spends several years "behind the counter."

Related Articles

Popular Topics: Drugmaker, Mevacor, Merck, Diabetes, Breast cancer, Prostate cancer, Heart disease, Depression, High cholesterol, Osteoporosis, Vaccines, Autism, ADHD, Infertility, Weight loss, Cancer, Alzheimer's, Trans fats, Acrylamides, Fluoride, Mercury	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/003888_drugmaker_Mevacor_Merck.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. <a href = "http://www.NaturalNews.com/003888_drugmaker_Mevacor_Merck.html">Drugmaker seeks over-the-counter status for cholesterol drug</a>
Receive our Natural Health Newsletter for FREE Subscribe now (it's free!) to win. We randomly choose a subscriber each month to send $100 in eco-home products or a RealGoods.com gift certificate (our choice). Plus, you'll receive FREE news, articles and action alerts from NaturalNews.com editors and join over 800,000 monthly readers who report extraordinary health improvements after becoming a subscriber! Receive breaking news alerts on natural health solutions, renewable energy, the environment, global warming and more. Receive a free instant download of our $29 Secret Sources guide that reveals top sources for little-known health and diet solutions.	Your Email Address: Free Subscription Code: Enter the numbers you see: 100% free of charge. Unsubscribe anytime. Absolutely no spam. We respect your email privacy.
Recommended Special Report: Seven Words that can Change the World by Joseph R. Simonetta Read this special report now... "Seven Words That Can Change the World reveals the astonishing, simple truths that have the power to forever transform our world for the better while freeing our minds from the enslavement of limiting beliefs. This is not a text for the simple-minded; it is a guiding philosophy for the mindful, intelligent few who are wise enough to seek out -- and recognize -- the higher simplicities of truly purposeful living." - Mike Adams, the Health Ranger, editor of NaturalNews.com	More on NaturalNews.com: • Streaming Health Ranger Videos • CounterThink Cartoons • FREE Special Reports • Podcasts